» Articles » PMID: 24072575

IDS ISYS Automated Intact Procollagen-1-N-terminus Pro-peptide Assay: Method Evaluation and Reference Intervals in Adults and Children

Overview
Specialties Biochemistry
Pathology
Date 2013 Sep 28
PMID 24072575
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We carried out a technical evaluation of the Immunodiagnostic Systems (IDS) automated intact procollagen-I N-terminus propeptide (PINP) assay on the iSYS platform, and established reference intervals for PINP in both adults and children.

Methods: Assay imprecision, recovery and interference were studied. Serum and plasma values were compared, and PINP stability was assessed. Using 828 specimens, IDS iSYS intact PINP and Roche E170 total PINP values were compared. Specimens from 597 adults and 485 children and adolescents were used to establish reference intervals for intact PINP.

Results: The method demonstrated good recovery and acceptable imprecision. The assay was unaffected by icterus and lipaemia, but haemolysis decreased measured PINP. Serum and plasma values were comparable. There was a non-linear relation between IDS intact and Roche total PINP values. Pre- and post-menopausal women had comparable PINP values, but there was a difference between women of different age groups. Serum PINP in men showed a decline in young age up to 45 years, but remained steady thereafter. Separate reference intervals were established for four age groups in women and for two age groups in men. Data for children were partitioned into four-year age groups, and these showed PINP to be high with no major gender differences until 12 years of age. Thereafter, values in females decreased in 13-16 years age groups and further in 17-20 years age groups, whereas PINP increased in boys of 13-16 years of age with a subsequent decline at 17-20 years.

Conclusions: The IDS iSYS PINP intact assay appears to be reliable. We have established gender- and age-related reference intervals for children and adults based on a relatively large healthy North European population.

Citing Articles

Reference Intervals (RIs) of the Bone Turnover Markers (BTMs) in Children and Adolescents: A Proposal for Effective Use.

Brescia V, Lovero R, Fontana A, Zerlotin R, Colucci S, Grano M Biomedicines. 2025; 13(1).

PMID: 39857618 PMC: 11759837. DOI: 10.3390/biomedicines13010034.


Bone turnover markers, and growth and bone parameters in infants participating in a vitamin D intervention study.

Persia S, Holmlund-Suila E, Valkama S, Enlund-Cerullo M, Rosendahl J, Andersson S Endocr Connect. 2024; 14(1.

PMID: 39555588 PMC: 11728877. DOI: 10.1530/EC-24-0482.


Demographic and disease-related factors impact bone turnover and vitamin D in children with hemato-oncological diseases.

Jackmann N, Gustafsson J, Utriainen P, Magnusson P, Harila A, Atanasova D JBMR Plus. 2024; 8(4):ziae017.

PMID: 38523666 PMC: 10961176. DOI: 10.1093/jbmrpl/ziae017.


Bone Turnover Markers: Basic Biology to Clinical Applications.

Schini M, Vilaca T, Gossiel F, Salam S, Eastell R Endocr Rev. 2022; 44(3):417-473.

PMID: 36510335 PMC: 10166271. DOI: 10.1210/endrev/bnac031.


Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk from Age 75 to 90.

Ivaska K, McGuigan F, Malmgren L, Gerdhem P, Johansson H, Kanis J Calcif Tissue Int. 2022; 111(3):288-299.

PMID: 35750934 PMC: 9395308. DOI: 10.1007/s00223-022-00996-8.